The evolving biology of small molecules: Controlling cell fate and identity

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 366, Issue 1575, 2011, Pages 2208-2221

  Efe, Jem A ^a   Ding, Sheng ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

Metabolites; Reprogramming; Signalling; Small molecules; Stem cells; Transdifferentiation

Indexed keywords

CYTOLOGY; EVOLUTIONARY BIOLOGY; GENETIC DIFFERENTIATION; HOMEOSTASIS; METABOLITE; MOLECULAR ANALYSIS; SIGNAL;

ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DRUG SCREENING; HUMAN; PHYSIOLOGY; PLURIPOTENT STEM CELL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; DRUG EVALUATION, PRECLINICAL; HUMANS; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION;

EID: 79960048750     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0006     Document Type: Review

References (97)

1. Drews, J. 2000 Drug discovery: a historical perspective. Science 287, 1960-1964. (doi:10.1126/science.287.5460. 1960)
2. Cayen, M. N. 2010 Early drug development: strategies and routes to first-in-human trials. Hoboken, NJ: Wiley.
3. Dandapani, S. & Marcaurelle, L. A. 2010 Current strategies for diversity-oriented synthesis. Curr. Opin. Chem. Biol. 14, 362-370. (doi:10.1016/j.cbpa.2010.03.018)
4. Wilk, W., Zimmermann, T. J., Kaiser, M. & Waldmann, H. 2010 Principles, implementation, and application of biology-oriented synthesis (BIOS). Biol Chem. 391, 491-497. (doi:10.1515/BC.2010.013)
5. Dobson, C. M. 2004 Chemical space and biology. Nature 432, 824-828. (doi:10.1038/nature03192)
6. Emre, N., Coleman, R. & Ding, S. 2007 A chemical approach to stem cell biology. Curr. Opin. Chem. Biol.11, 252-258. (doi:10.1016/j.cbpa.2007.04.024)
7. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S. & Jones, J. M. 1998 Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147. (doi:10.1126/science.282.5391.1145)
8. Evans, M. J. & Kaufman, M. H. 1981 Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156. (doi:10.1038/292154a0)
9. Kanatsu-Shinohara, M. et al. 2004 Generation of pluripotent stem cells from neonatal mouse testis. Cell 119, 1001-1012. (doi:10.1016/j.cell.2004.11.011)
10. Brons, I. G. et al. 2007 Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195. (doi:10.1038/nature05950)
11. Wagers, A. J. & Weissman, I. L. 2004 Plasticity of adult stem cells. Cell 116, 639-648. 8674(04)00208-9)
12. Niwa, H., Burdon, T., Chambers, I. & Smith, A. 1998 Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048-2060. (doi:10.1101/gad.12.13.2048)
13. Nichols, J., Chambers, I., Taga, T. & Smith, A. 2001 Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 128, 2333-2339.
14. Li, Y., McClintick, J., Zhong, L., Edenberg, H. J., Yoder, M. C. & Chan, R. J. 2005 Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105, 635-637. (doi:10.1182/blood-2004-07-2681)
15. Ying, Q. L. & Smith, A. G. 2003 Defined conditions for neural commitment and differentiation. Methods Enzymol.365, 327-341. (doi:10.1016/S0076-6879(03) 65023-8)
16. Chen, S., Do, J. T., Zhang, Q., Yao, S., Yan, F., Peters, E. C., Scholer, H. R., Schultz, P. G. & Ding, S. 2006 Self-renewal of embryonic stem cells by a small molecule. Proc. Natl Acad. Sci. USA 103, 17266-17271. (doi:10.1073/pnas.0608156103)
17. Ying, Q. L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P. & Smith, A. 2008 The ground state of embryonic stem cell self-renewal. Nature 453, 519-523. (doi:10.1038/nature06968)
18. Yuan, H., Corbi, N., Basilico, C. & Dailey, L. 1995 Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9, 2635-2645. (doi:10.1101/gad.9.21.2635)
19. Stefanovic, S., Abboud, N., Desilets, S., Nury, D., Cowan, C. & Puceat, M. 2009 Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J. Cell Biol. 186, 665-673. (doi:10.1083/jcb.200901040)
20. Snyder, M., Huang, X. Y. & Zhang, J. J. 2010 Stat3 directly controls the expression of Tbx5, Nkx2.5, and GATA4 and is essential for cardiomyocyte differentiation of P19CL6 cells. J. Biol. Chem. 285, 23639-23646. (doi:10.1074/jbc.M110.101063)
21. Wagner, R.T., Xu, X., Yi, F., Merrill, B. J. & Cooney, A. J. 2010 Canonical Wnt/b-catenin regulation of liver receptor homolog-1 mediates pluripotency gene expression. Stem Cells. 28, 1794-1804. (doi:10.1002/stem.502)
22. Yang, W. et al. 2009 Pluripotin combined with leukemia inhibitory factor greatly promotes the derivation of embryonic stem cell lines from refractory strains. Stem Cells 27, 383-389. (doi:10.1634/stemcells.2008-0974)
23. Hanna, J. et al. 2009 Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 4, 513-524. (doi:10.1016/j.stem.2009.04.015)
24. Nichols, J., Jones, K., Phillips, J. M., Newland, S. A., Roode, M., Mansfield, W., Smith, A. & Cooke, A.2009 Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat. Med. 15, 814-818. (doi:10.1038/nm.1996)
25. Burton, P. et al. 2010 Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells. Biochem. Soc. Trans. 38, 1058-1061. (doi:10.1042/BST0381058)
26. Xu, Y., Zhu, X., Hahm, H. S., Wei, W., Hao, E., Hayek, A. & Ding, S. 2010 Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and selfrenewal by small molecules. Proc. Natl Acad. Sci. USA 107 8129-8134. (doi:10.1073/pnas.1002024107)
27. Armstrong, L. et al. 2006 The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum. Mol. Genet. 15, 1894-1913. (doi:10.1093/hmg/ddl112)
28. Paling, N. R., Wheadon, H., Bone, H. K. & Welham, M. J. 2004 Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J. Biol. Chem. 279, 48063-48070. (doi:10.1074/jbc.M406467200)
29. Burdon, T., Stracey, C., Chambers, I., Nichols, J. & Smith, A. 1999 Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev. Biol. 210, 30-43. (doi:10.1006/dbio.1999.9265)
30. Yanes, O. et al. 2010 Metabolic oxidation regulates embryonic stem cell differentiation. Nat. Chem. Biol. 6, 411-417. (doi:10.1038/nchembio.364)
31. Ezashi, T., Das, P. & Roberts, R. M. 2005 Low O2 tensions and the prevention of differentiation of hES cells. Proc. Natl Acad. Sci. USA 102, 4783-4788. (doi:10.1073/pnas.0501283102)
32. Lin, Q., Lee, Y. J. & Yun, Z. 2006 Differentiation arrest by hypoxia. J. Biol. Chem. 281, 30678-30683. (doi:10.1074/jbc.C600120200)S
33. Tsatmali, M., Walcott, E. C. & Crossin, K. L. 2005 Newborn neurons acquire high levels of reactive oxygen species and increased mitochondrial proteins upon differentiation from progenitors. Brain Res. 1040, 137-150. (doi:10.1016/j.brainres.2005.01.087)
34. Garcia-Gonzalo, F. R. & Izpisua Belmonte, J. C. 2008 Albumin-associated lipids regulate human embryonic stem cell self-renewal. PLoS ONE 3, e1384. (doi:10.1371/journal.pone.0001384)
35. Murry, C. E. & Keller, G. 2008 Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132, 661-680. (doi:10.1016/j.cell.2008.02.008)
36. Zhu, S., Wurdak, H., Wang, J., Lyssiotis, C. A., Peters, E. C., Cho, C. Y., Wu, X. u & Schultz, P. G. 2009 A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell 4, 416-426. (doi:10.1016/j.stem.2009.04.001)
37. Borowiak, M., Maehr, R., Chen, S., Chen, A. E., Tang, W., Fox, J. L., Schreiber, S. & Melton, D. A. 2009 Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 4, 348-358. (doi:10.1016/j.stem.2009.01.014)
38. Ying, Q. L., Stavridis, M., Griffiths, D., Li, M. & Smith, A. 2003 Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 21, 183-186. (doi:10.1038/nbt780)
39. Li, X. J., Du, Z. W., Zarnowska, E. D., Pankratz, M., Hansen, L. O., Pearce, R. A. & Zhang, S.-C. 2005 Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 23, 215-221. (doi:10.1038/nbt1063)
40. Kattman, S. J., Huber, T. L. & Keller, G. M. 2006 Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell. 11, 723-732. (doi:10.1016/ j.devcel.2006.10.002)
41. Laflamme, M. A. et al. 2007 Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol.25, 1015-1024. (doi:10.1038/nbt1327)
42. D'Amour, K. A., Agulnick, A. D., Eliazer, S., Kelly, O. G., Kroon, E. & Baetge, E. E. 2005 Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534-1541. (doi:10.1038/nbt1163)
43. Ding, S., Wu, T. Y., Brinker, A., Peters, E. C., Hur, W., Gray, N. S. & Schultz, P. G. 2003 Synthetic small molecules that control stem cell fate. Proc. Natl Acad. Sci. USA 100, 7632-7637. (doi:10.1073/pnas.0732087100)
44. Wu, X., Ding, S., Ding, Q., Gray, N. S. & Schultz, P. G.2004 Small molecules that induce cardiomyogenesis in embryonic stem cells. J. Am. Chem. Soc. 126, 1590-1591. (doi:10.1021/ja038950i)
45. Wu, X., Ding, S., Ding, Q., Gray, N. S. & Schultz, P. G.2002 A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. J. Am. Chem. Soc. 124, 14520-14521. (doi:10.1021/ ja0283908)
46. Lu, Q., Paredes, M., Zhang, J. & Kosik, K. S. 1998 Basal extracellular signal-regulated kinase activity modulates cell-cell and cell-matrix interactions. Mol. Cell Biol. 18, 3257-3265.
47. Qyang, Y. et al. 2007 The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/ beta-catenin pathway. Cell Stem Cell 1, 165-179. (doi:10.1016/j.stem.2007.05.018)
48. Meijer, L. et al. 2003 GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem. Biol. 10, 1255-1266. (doi:10.1016/j.chembiol.2003.11.010)
49. North, T. E. et al. 2007 Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447, 1007-1011. (doi:10.1038/nature05883)
50. Broxmeyer, H. E. 2008 Chemokines in hematopoiesis. Curr. Opin. Hematol. 15, 49-58. (doi:10.1097/MOH.0b013e3282f29012)
51. Grayson, P., Mendlein, J., Thies, S. & Yingling, J. 2009 Stem cell modulators (SCMs): a small molecule and biologic approach to stem cell modulators. Drug Discov. Today Ther. Strateg. 6, 141-145. (doi:10.1016/J.DD STR.2009.06.005)
52. Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E. & Wu, D. 2005 Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280, 19883-19887. (doi:10.1074/jbc.M413274200)
53. Semenov, M., Tamai, K. & He, X. 2005 SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem. 280, 26770-26775. (doi:10.1074/jbc. M504308200)
54. Binnerts, M. E. et al. 2007 R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. Proc. Natl Acad. Sci. USA 104, 14 700-14 705. (doi:10.1073/pnas.0702305104)
55. Takahashi, K. & Yamanaka, S. 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (doi:10.1016/j.cell.2006.07.024)
56. Kim, J. B. et al. 2009 Oct4-induced pluripotency in adult neural stem cells. Cell 136, 411-419. (doi:10.1016/j.cell.2009.01.023).
57. Aasen, T. et al. 2008 Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276-1284. (doi:10.1038/nbt.1503)
58. Loh, Y. H. et al. 2009 Generation of induced pluripotent stem cells from human blood. Blood 113, 5476-5479. (doi:10.1182/blood-2009-02-204800)
59. Loh, Y. H. et al. 2009 Generation of induced pluripotent stem cells from human blood. Blood 113, 5476-5479.(doi:10.1182/blood-2009-02-204800)
60. Abujarour, R. & Ding, S. 2009 Induced pluripotent stem cells free of exogenous reprogramming factors. Genome Biol. 10, 220. (doi:10.1186/gb-2009-10-5-220)
61. Zhou, H. et al. 2009 Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384. (doi:10.1016/j.stem.2009.04.005)
62. Ohm, J. E. et al. 2010 Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Res. 70, 7662-7673. (doi:10.1158/0008-5472.CAN-10-1361)
63. Marion, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M. & Blasco, M. A. 2009 A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149-1153. (doi:10.1038/nature08287),
64. Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M. & Belmonte, J. C. I. 2009 Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140-1144. (doi:10.1038/nature08311)
65. Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Canamero, M., Blasco, M. A. & Serrano, M. l 2009 The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136-1139. (doi:10.1038/nature08290)
66. Hester, M.E., Song, S., Miranda, C. J., Eagle, A., Schwartz, P. H. & Kaspar, B. K. 2009 Two factor reprogramming of human neural stem cells into pluripotency. PLoS ONE 4, e7044. (doi:10.1371/journal.pone.0007044)
67. Mali, P. et al. 2010 Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency- associated genes. Stem Cells 28, 713-720. (doi:10.1002/stem.402)
68. Shi, Y., Desponts, C., Do, J. T., Hahm, H. S., Scholer, H. R. & Ding, S. 2008 Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568-574. (doi:10.1016/j.stem.2008.10.004)
69. Shi, Y., Do, J. T., Desponts, C., Hahm, H. S., Scholer, H. R. & Ding, S. 2008 A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2, 525-528. (doi:10.1016/j.stem.2008.05.011)
70. Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W. & Melton, D. A. 2008 Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26, 1269-1275. (doi:10.1038/nbt.1502)
71. Li, W. et al. 2009 Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 27, 2992-3000. (doi:10.1002/stem.240)
72. Ichida, J. K. et al. 2009 A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5, 491-503. (doi:10.1016/j.stem.2009.09.012)
73. Zhou, H. & Ding, S. 2010 Evolution of induced pluripotent stem cell technology. Curr. Opin. Hematol. 17, 276-280. (doi:10.1097/MOH.0b013e328339f2ee)
74. Maherali, N. & Hochedlinger, K. 2009 Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr. Biol. 19, 1718-1723. (doi:10.1016/j.cub.2009.08.025)
75. Lyssiotis, C. A. et al. 2009 Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc. Natl Acad. Sci. USA 106, 8912-8917. (doi:10.1073/pnas.0903860106)
76. Lin, T. et al. 2009 A chemical platform for improved induction of human iPSCs. Nat. Methods 6, 805-808. (doi:10.1038/nmeth.1393)
77. Nagy, A., Gocza, E., Diaz, E. M., Prideaux, V. R., Ivanyi, E., Markkula, M. & Rossant, J. 1990 Embryonic stem cells alone are able to support fetal development in the mouse. Development 110, 815-821.
78. Wei, C. L. et al. 2005 Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state. Stem Cells 23, 166-185. (doi:10.1634/stemcells.2004-0162)
79. Ohtsuka, S. & Dalton, S. 2008 Molecular and biological properties of pluripotent embryonic stem cells. Gene Ther. 15, 74-81. (doi:10.1038/sj.gt.3303065)
80. Qi, X., Li, T. G., Hao, J., Hu, J., Wang, J., Simmons, H., Miura, S., Mishina, Y. & Zhao, G.-Q. 2004 BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogenactivated protein kinase pathways. Proc. Natl Acad. Sci. USA 101, 6027-6032. (doi:10.1073/pnas.0401367101)
81. Guo, G. & Smith, A. 2010 A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development 137, 3185-3192. (doi:10.1242/dev.052753)
82. Guo, G., Yang, J., Nichols, J., Hall, J. S., Eyres, I., Mansfield, W. & Smith, A. 2009 Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136, 1063-1069. (doi:10.1242/dev.030957)
83. Zhou, H. et al. 2010 Conversion of mouse epiblast stem cells to an earlier pluripotency state by small molecules. J. Biol. Chem. 285, 29676-29680. (doi:10.1074/jbc. c110.150599)
84. Li, W. et al. 2009 Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4, 16-19. (doi:10.1016/j.stem.2008.11.014)
85. Hanna, J. et al. 2010 Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl Acad. Sci. USA 107, 9222-9227. (doi:10.1073/pnas.1004584107)
86. Lengner, C. J. et al. 2010 Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141, 872-883. (doi:10.1016/j.cell.2010.04.010)
87. Wang, J., Alexander, P., Wu, L., Hammer, R., Cleaver, O. & McKnight, S. L. 2009 Dependence of mouse embryonic stem cells on threonine catabolism. Science 325, 435-439. (doi:10.1126/science.1173288)
88. Buehr, M. et al. 2008 Capture of authentic embryonic stem cells from rat blastocysts. Cell 135, 1287-1298. (doi:10.1016/j.cell.2008.12.007)
89. Li, P. et al. 2008 Germline competent embryonic stem cells derived from rat blastocysts. Cell 135, 1299-1310. (doi:10.1016/j.cell.2008.12.006)
90. Kawamata, M. & Ochiya, T. 2010 Generation of genetically modified rats from embryonic stem cells. Proc. Natl Acad. Sci. USA 107, 14223-14228. (doi:10.1073/pnas.1009582107)
91. Tong, C., Li, P., Wu, N. L., Yan, Y. & Ying, Q. L. 2010 Production of p53 gene knockout rats by homologous recombination in embryonic stem cells. Nature 467, 211-213. (doi:10.1038/nature09368)
92. Kim, K. et al. 2010 Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290. (doi:10.1038/nature09342)
93. Mikkelsen, T. S. et al. 2008 Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55. (doi:10.1038/nature07056)
94. Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T.W. & Smith, A. 2008 Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6, e253. (doi:10.1371/journal. pbio.0060253)
95. Efe, J. A., Hilcove, S., Kim, J., Zhou, H., Ouyang, K., Wang, G., Chen, J. & Ding, S. 2011 Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 13, 215-222. (doi:10.1038/ncb2164)
96. Ieda, M., Fu, J. D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G. & Srivastava, D. 2010 Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386. (doi:10.1016/j.cell.2010.07.002)
97. Kim, J., Efe, J. A., Zhu, S., Talantova, M., Yuan, X., Wang, S., Lipton, S. A., Zhang, K. & Ding, S. 2011 Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl Acad. Sci. USA 108, 7838-7843. (doi:10.1073/pnas.1103113108)